Dynavax Technologies

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$94,876
$95,442
$68,164
$72,032
Gross Profit
80,473
81,407
54,395
58,622
EBITDA
31,889
24,631
-94,435
12,267
EBIT
29,795
22,592
-96,471
10,196
Net Income
26,927
18,721
-96,099
7,050
Net Change In Cash
94,876
95,442
68,164
72,032
Free Cash Flow
32,592
21,979
-23,567
49,533
Cash
160,247
99,101
51,720
95,883
Basic Shares
136,468
138,356
124,871
153,022

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$277,246
$232,284
$722,683
$439,442
Gross Profit
227,801
182,117
460,530
265,870
EBITDA
45,701
9,666
307,699
95,755
EBIT
37,649
2,390
301,031
88,697
Net Income
27,309
-6,389
293,156
76,713
Net Change In Cash
277,246
232,284
722,683
439,442
Cost of Revenue
-233,754
405,529
Free Cash Flow
60,160
96,459
55,577
326,051
Cash
95,883
150,279
202,004
436,189
Basic Shares
133,344
128,733
150,797
133,006

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$0.21
2025-06-30
$0.14
2025-03-31
-$0.009